A group of EU lawmakers has taken the UK-led “Dying to Work” campaign to the EU in an effort to mobilise support for terminally ill patients across Europe, who face unfair treatment at work.
In view of the growing burden of metastatic breast cancer (MBC), data on recurrence of the disease is urgently needed to support further research into the specific needs of patients.
Metastatic breast cancer (MBC) has long been disregarded by advocacy groups, researchers and policymakers. As a result, little is known about the scope of the disease, its economic burden and the best way to treat it.
A group of metastatic breast cancer experts has urged policymakers to empower patients with greater choice and participation in their treatment and care, to improve the quality of life of patients, their carers and families.
Metastatic breast cancer (MBC) kills half a million women in the EU every year, yet progress on the quality of life and survival time of MBC patients remains elusive. MEPs addressed the need to improve patient outcomes with a policy roadmap launched on Tuesday (17 October).
October is breast cancer awareness month. The pink ribbon movement has achieved progress in spreading awareness and pushing for widespread cancer screening.
